Second phase of Thalassemia Bal Sewa Yojna launched
Part of: GS Prelims and GS-II – Health
In news
The second phase of “Thalassemia Bal Sewa Yojna” was recently launched for the underprivileged Thalassemic patients.
Important value additions
Thalassemia Bal Sewa Yojna
Launched in: 2017
It is a Coal India CSR funded Hematopoietic Stem Cell Transplantation (HSCT) program.
Aim: To provide a one-time cure opportunity for Haemoglobinopathies like Thalassaemia and Sickle Cell Disease for patients who have a matched family donor.
The CSR initiative was targeted to provide financial assistance to a total of 200 patients by providing a package cost not exceeding Rs. 10 lakhs per HSCT.
Thalassemia
Haemoglobinopathies, such as Thalassemia and sickle cell disease are inherited disorders of red blood cells.
They are preventable.
People with thalassaemia are not able to make enough haemoglobin due to which oxygen cannot get to all parts of the body.
Due to this, organs are unable to function properly.
There are two major types of thalassaemia, alpha and beta. These are named for the two protein chains that make up normal haemoglobin.
In India, Thalassemia Major (TM) and the severe form of Thalassemia Intermedia (TI) constitute the major burden of disease.